Phosphorylation of β-d-Ribosylbenzimidazoles Is Not Required for Activity against Human Cytomegalovirus

We have previously reported that 2,5,6-trichloro-1-(β-d-ribofuranosyl)benzimidazole (TCRB) and its 2-bromo analog (2-bromo-5,6-dichloro-1-(β-d-ribofuranosy)benzimidazole [BDCRB]) are potent and selective inhibitors of human cytomegalovirus (HCMV) replication that block viral DNA maturation via HCMV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krosky, Paula M., Borysko, Katherine Z., Nassiri, M. Reza, Devivar, Rodrigo V., Ptak, Roger G., Davis, Michelle G., Biron, Karen K., Townsend, Leroy B., Drach, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2002
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC127035/
https://ncbi.nlm.nih.gov/pubmed/11796361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.2.478-486.2002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados